TG4010: A therapeutic vaccine against MUC1 expressing tumors

相似書籍

• Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial.
  由: Christine Rotonda, et al.
  出版: (2015-01-01)
• Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial
  由: Rotonda, Christine, et al.
  出版: (2015)
• Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
  由: Tosch, Caroline, et al.
  出版: (2017)
• TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study
  由: Quoix, Elisabeth, et al.
  出版: (2014)
• TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial
  由: Nemunaitis, John, et al.
  出版: (2015)